Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

PURPOSE: Given that the clinical course of oxaliplatin-induced neuropathy is not well defined, the current study was performed to better understand clinical parameters associated with its presentation. METHODS: Acute and chronic neuropathy was evaluated in patients receiving adjuvant FOLFOX (fluorou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Pachman, Deirdre R., Qin, Rui, Seisler, Drew K., Smith, Ellen M.L., Beutler, Andreas S., Ta, Lauren E., Lafky, Jacqueline M., Wagner-Johnston, Nina D., Ruddy, Kathryn J., Dakhil, Shaker, Staff, Nathan P., Grothey, Axel, Loprinzi, Charles L.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2015
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4606060/
https://ncbi.nlm.nih.gov/pubmed/26282635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.58.8533
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars